Posted on January 6, 2017 by Sitemaster
A new article in the journal Urologic Oncology has highlighted an association between the occurrence of advanced bladder cancer and the related finding of prostate cancer among such patients who have their prostate removed along with their bladder at the time of initial surgery for the bladder cancer (i.e., a radical cystoprostatectomy). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: advanced, bladder, cancer, cystectomy, cystoprostatectomy, risk | 7 Comments »
Posted on March 2, 2012 by Sitemaster
Clinical stage T4 prostate cancer is characterized by prostate tumors that have grown through the prostate capsule and into or even through the bladder wall. There is no agreed or “standard” form of first-line treatment for this form of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cystectomy, cystoprostatectomy, outcome, radical, stage, T4 | Leave a comment »
Posted on January 27, 2009 by Sitemaster
Today’s news deals with such items as:
- Toxicities associated with hypofractionated, intensity-modulated radiation therapy
- Incidental prostate cancer in male patients undergoing radical cystoprostatectomy for treatment of bladder cancer
- A Spanish review of photodynamic therapy
- A proposed mechanism of action for the investigational drug Apoptone™ (HE3235) … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: Apoptone, cystoprostatectomy, HE3235, hypofractionated, IMRT, photodynamic therapy | Leave a comment »